Kenneth I Kaitin, PhD

Ken Kaitin

Professor & Director, Tufts Center for the Study of Drug Development



BS, Neurobiology & Behavior, Cornell University
MS, Pharmacology & Experimental Toxicology, University of Rochester
PhD, Pharmacology & Experimental Toxicology, University of Rochester
Postdoctoral Training, Stanford University



Campus: Boston
Office: 75 Kneeland, Suite 1100

Contact Information

Office Phone: 617-636-2181
E-mail   Send an e-mail


Graduate Programs

Clinical & Translational Science, Pharmacology & Experimental Therapeutics


Research Synopsis

My work focuses on trends in the development and regulation of new pharmaceutical products including the impact of legislative and regulatory initiatives designed to speed the process of new drug development and review. I am particularly interested in the economic, legal, scientific, and political factors that contribute to the slow pace and high cost of pharmaceutical R&D, and on new models of bio/pharmaceutical innovation. I also play an important role in the MS in Development and Regulation of Medicines and Devices, a program based in the Public Health and Professional Degree Programs unit at Tufts School of Medicine.


Learn more about The Center for the Study of Drug Development  info

Apply to the Sackler School


The priority application deadlines are as follows:

December 1: Basic Science Division PhD Programs

February 15: Building Diversity in Biomedical Sciences

March 31: Post-Baccalaureate Research Program

May 1: Clinical & Translational Science, MS in Pharmacology & Drug Development